Applied Therapeutics, Inc. (APLT) stock rallied over 2.89% intraday to trade at $0.89 a share on NASDAQ. The stock opened with a loss of -5.32% at $0.885 and touched an intraday high of $0.92, rising 2.89% against the last close of $0.865. The stock went to a low of $0.86 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Applied Therapeutics, Inc. (NASDAQ: APLT) stock price is $0.89 as of the last check on Tuesday, July 5. During the trading session, APLT stock reached the peak price of $0.92 while $0.86 was the lowest point it dropped to.
The NASDAQ listed APLT is part of Biotechnology industry that operates in the broader Health Care sector. Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications.
Dr. Charles Silberstein M.D., CFA
CFO & Head of Bus. Devel.
Mr. Chids Mahadevan
VP of Fin. & Chief Accounting Officer
Dr. Shoshana Shendelman Ph.D.
Chair of the Board of Directors, Founder, Pres, CEO & Sec.
Dr. Riccardo Perfetti M.D., Ph.D.
Chief Medical Officer
APLT stock traded closed the last session at $0.89, which is $0.02 or 2.89% lower than its previous close of $0.865. APLT's current trading price is 22.30% lower than its 52-week high of $22.27 where as its distance from 52-week low of 0.73% is -96.00%.
Number of APLT employees currently stands at -. APLT operates from 545 Fifth Avenue, Suite 1400, New York, NY 10017, United States.
Official Webiste of $APLT is: https://www.appliedtherapeutics.com
APLT stock volume for the day was 449,410 shares while in the previous session number of APLT shares traded was 428,953 . The average number of APLT shares traded daily for last 3 months was 420.25 Thousands.
The percentage change in APLT stock occurred in the recent session was 2.89% while the dollar amount for the price change in APLT stock was $0.02.
In the recent session, the day high for APLT stock was $0.92 while the low for APLT stock touched on the day was $0.86.
The market value of APLT currently stands at 25.62 Million with its latest stock price at $0.89 and 26.22 Million of its shares outstanding.